ANTI-ADALIMUMAB ANTIBODIES (ADL) - ANVISA Registration 80464810760

Access comprehensive regulatory information for ANTI-ADALIMUMAB ANTIBODIES (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810760 and manufactured by IMMUNDIAGNOSTIK. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including IMMUNDIAGNOSTIK, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
4 Competitors
80464810760
Registration Details
ANVISA Registration Number: 80464810760
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

IDKmonitor® Adalimumab total ADA ELISA
Risk Class II

Registration Details

80464810760

25351000868202193

09377976000152

Company Information

IMMUNDIAGNOSTIK
Germany
PT: ALEMANHA

Dates and Status

Feb 11, 2021

VIGENTE

09/18/2025 19:00:01